Cutaneous adverse reactions following SARS‐CoV‐2 vaccine booster dose: a real‐life multicentre experience.

Cutaneous adverse reactions following SARS-CoV-2 vaccine booster dose: a real-life multicentre experience All patients denied any adverse reaction after the first two doses of vaccination and, at the time of the rash, no patient presented with symptoms of COVID-19 nor tested positive for Sars-Cov-2 nor had been in contact with a symptomatic subject. As for vaccine type, eight patients received BNT162b2 homologous booster, four patients received BNT/1273 heterologous booster and one patient underwent ChAd/1273. [Extracted from the article]